Cited by CrossRef (16)
- HyeIn Jung, Hyun Jung Kim, Eun Sung Choi, Ju Yup Lee, Kyung Sik Park, Kwang Bum Cho, Yoo Jin Lee, Lise Lotte Gluud. Effectiveness of oral phloroglucinol as a premedication for unsedated esophagogastroduodenoscopy: A prospective, double-blinded, placebo-controlled, randomized trial. PLoS ONE 2021;16:e0255016
- Bénédicte Caron, Subrata Ghosh, Silvio Danese, Laurent Peyrin-Biroulet. Identifying, Understanding, and Managing Fecal Urgency in Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology 2023;21:1403
- S. Daisy Precilla, Shreyas S. Kuduvalli, E. Angeline Praveena, Saravanabhavan Thangavel, T.S. Anitha. Integration of synthetic and natural derivatives revives the therapeutic potential of temozolomide against glioma- an in vitro and in vivo perspective. Life Sciences 2022;301:120609
- Marco Fabbrini, Federica D’Amico, Monica Barone, Gabriele Conti, Mariachiara Mengoli, Patrizia Brigidi, Silvia Turroni. Polyphenol and Tannin Nutraceuticals and Their Metabolites: How the Human Gut Microbiota Influences Their Properties. Biomolecules 2022;12:875
- Lakshmi Shanmugam, G. Devanand Venkatasubbu, Megala Jayaraman. Hyaluronan-based nano-formulation with mesoporous silica enhances the anticancer efficacy of phloroglucinol against gastrointestinal cancers. International Journal of Biological Macromolecules 2024;265:130856
- Esther Colomier, Joost Algera, Chloé Melchior. Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea. Front. Pharmacol. 2021;11
- Liang Zheng, Weimin Lu, Qi Xiao, Yaoliang Lai, Heng Fan, Yuling Sun, Dawei Huang, Yuanyuan Wang, Zhen Li, Zhengyan Jiang, Xingxing Liu, Lijuan Zhang, Dongmei Zuo, Zhexing Shou, Qing Tang, Huisuo Huang, Yongqiang Yang, Zongxiang Tang, Jun Xiao. Assessing the post-treatment therapeutic effect of pinaverium in irritable bowel syndrome: a randomized controlled trial. Sci Rep 2021;11
- O. Z. Kim. Efficacy and Safety of Phlorloglucinol in the Treatment of Patients with Irritable Bowel Syndrome: Randomized Double-blind, Non-inferiority Trial, Compared With Pinaverium. ESGE Days 2024. 2024.
- Caroline Valibouze, Caroline Dubuquoy, Philippe Chavatte, Michaël Genin, Veronique Maquet, Salvatore Modica, Pierre Desreumaux, Christel Rousseaux. Chitin-glucan improves important pathophysiological features of irritable bowel syndrome. World J Gastroenterol 2024;30:2258
- Yang Liu, Iva Fernandes, Nuno Mateus, Hélder Oliveira, Fuliang Han. The Role of Anthocyanins in Alleviating Intestinal Diseases: A Mini Review. J. Agric. Food Chem. 2024;72:5491
- Seyedeh Faezeh Taghizadeh, Ali Panahi, Marziyeh Esmaeilzadeh Kashi, Nadine Kretschmer, Javad Asili, Seyed Ahmad Emami, Majid Azizi, Abolfazl Shakeri. Structural Diversity of Complex Phloroglucinol Derivatives from Eucalyptus Species. Chemistry & Biodiversity 2022;19
- Eun-Jeong Yang, Hyunju Kim, Hye-Sun Kim, Moon-Jeong Chang. Phloroglucinol attenuates oligomeric amyloid beta peptide1-42-induced astrocytic activation by reducing oxidative stress. Journal of Pharmacological Sciences 2021;145:308
- Krzysztof Drygalski, Eliza Fereniec, Anna Zalewska, Adam Krętowski, Małgorzata Żendzian-Piotrowska, Mateusz Maciejczyk. Phloroglucinol prevents albumin glycation as well as diminishes ROS production, glycooxidative damage, nitrosative stress and inflammation in hepatocytes treated with high glucose. Biomedicine & Pharmacotherapy 2021;142:111958
- Taraneh Mousavi, Shekoufeh Nikfar, Mohammad Abdollahi. An update on efficacy and safety considerations for the latest drugs used to treat irritable bowel syndrome. Expert Opinion on Drug Metabolism & Toxicology 2020;16:583
- Fan Wu, Yue Chen, Caihong Zheng. Efficacy of phloroglucinol for acceleration of labour: a systematic review and meta‑analysis. Arch Gynecol Obstet 2021;304:421
- Rui Cai, Jinli Lin, Yao Liu, Linhao Zhang, Xueying Li. Effects of Phloroglucinol on Embryo Transfer: A Systematic Review and Meta-Analysis. Gynecol Obstet Invest 2024;89:376